Moonlight Therapeutics

Moonlight Therapeutics is a biotechnology company developing safe, effective and patient-friendly treatments for people suffering from food allergies.

[Moonlight Therapeutics @MLTherapeutics]

Moonlight is proud to announce that we have received a clinical trial grant from #NIAID to evaluate our intradermal treatment for #peanutallergy, MOON101, in peanut allergic children and adults.
https://t.co/3aw2wfExrx

[Allergic Living @AllergicLiving]

Team at @UMFoodAllergy find microneedle patch desensitized peanut-allergic mice.

“We compared a minimally invasive, 5-minute microneedle device vs 24-hour skin patch & found the microneedle device far superior.” Next up: human clinical trial. @umichmedicine

[Moonlight Therapeutics @MLTherapeutics]

@UMFoodAllergy @fsgimt Thank you Dr Jessica O'Konek and her team at the @UMFoodAllergy for your hard work on this research that highlights the potential benefits of our treatment approach.

[Mary H. Weiser Food Allergy Center @UMFoodAllergy]

New #umich @UMFoodAllergy research finds microneedle delivery superior to EPIT in #peanutallergy desensitization study. Just out today in @fsgimt Immunotherapy @MLTherapeutics
https://t.co/zHKR8dBkzB

[Moonlight Therapeutics @MLTherapeutics]

We completed a #preIND meeting with the FDA to discuss the regulatory pathway for the development of MOON101 for the treatment of #peanutallergy. We received guidance on a first-in-human clinical trial for MOON101 in peanut allergic children and adults.
https://t.co/gnea9fPzKC

[Moonlight Therapeutics @MLTherapeutics]

On Friday, Dr Jessica O'Konek of the University of Michigan Mary H. Weiser Food Allergy Center will be presenting some new data on the use of our targeted #peanutallergy treatment at EAACI #PAAM21. @UMFoodAllergy
https://t.co/ykbnzZ5gN6

[Moonlight Therapeutics @MLTherapeutics]

Happy to announce we received a $1.9M grant for developing our #peanutallergy treatment. Thank you to #NIAID for the suuport. https://t.co/XFbihyOYyS via @PRWeb

[Moonlight Therapeutics @MLTherapeutics]

Save the date: @JRB_UMFA @UMFoodAllergy MHWFAC Online Research Symposium- Clinical Aspects of Food Allergy Research June 2 2021 https://t.co/yc6P33ne7L

[Moonlight Therapeutics @MLTherapeutics]

Excited to announce that research using our targeted approach to treating #peanutallergy conducted with the #UNC Food Allergy Initiative will be presented at #AAAAI21 in the late breaking oral session on Sat Feb 27. https://t.co/ArsNZUtgpD. We hope this is the first of many.

[Moonlight Therapeutics @MLTherapeutics]

@FoodAllergy To Grant $15m To The @broadinstitute Of MIT And Harvard To Decipher Brain-Gut Connections In Food Allergy https://t.co/9nTPvWveRM. Great to hear more food allergy research being funded.

[Moonlight Therapeutics @MLTherapeutics]

Our CEO, Samir Patel, has been selected by @gtalumni to be in the inaugural class of 40 under 40 innovators and trendsetters. He is being recognized for his efforts to develop therapies for eye diseases and for #foodallergy.

https://t.co/DQnkY60Zdb

[Moonlight Therapeutics @MLTherapeutics]

Thank you @medcitynews for selecting us as a finalist for the MedCity INVEST #mcinvest virtual conference. We are excited to be presenting our approach to helping the millions who are suffering from #foodallergies #peanutallergy.

[MedCity News @medcitynews]

Check out the #biopharma companies who made the finals of our INVEST Pitch Perfect contest. Read for details on the event and how to register at the Earlybird rate today. https://t.co/1kmZW0pVjs @Biolife4D @bio_libera
@MLTherapeutics @Kettilc #mcINVEST

[Moonlight Therapeutics @MLTherapeutics]

Nice conversation with Dr. Kari Nadeau: fighting to end #foodallergies https://t.co/atwswlBIgY
#peanutallergy

[Moonlight Therapeutics @MLTherapeutics]

Happy to announce that we have secured our first round of private #funding. Looking forward to continuing the development of our microneedle based #peanutallergy treatment. Thank you to our new #investors and our current funding from #NIH #NIAID. https://t.co/KdSKceSWvf #FAAW

[Moonlight Therapeutics @MLTherapeutics]

@ATLergist @US_FDA @aimmune Congrats to all involved in helping to make this happen. It is truly a major accomplishment. I hope the effort to bring meaningful therapies doesn't stop here.

[Moonlight Therapeutics @MLTherapeutics]

One takeaway from the treatment session of #foodallergy symposium at #ACAAI19: no single food allergy treatment in development will be suited for all patients. There are pro/cons for each of the approaches. Shared decision making willl be key for each person/ family.

[Moonlight Therapeutics @MLTherapeutics]

Looking forward to an exciting day at @ACAAI International #foodallergy Symposium in Houston on Nov 8 with experts such as @ATLergist @VenterCarina and @WayneShreffler. Thanks @AllergyKidsDoc for organizing.

https://t.co/qnLynz6TKL

[Moonlight Therapeutics @MLTherapeutics]

Happy to announce that our scientific founder has published an article on using microneedles to treat #peanutallergy. At Moonlight Therapeutics we hope to demonstrate that this targeted approach is safe and effective in patients with #foodallergies.
https://t.co/lsGANfOWsq

[Moonlight Therapeutics @MLTherapeutics]

Ready for #Halloween this season now that we have #foodallergy friendly treats (glow sticks and mini Jenga blocks) and #TealPumpkin #tealpumpkinproject.

[Moonlight Therapeutics @MLTherapeutics]

We're honored to be selected to present on the innovation stage at the #GaBioSummit on Oct 8. We'll be talking about how we're using or targeted #immunotherapy platform for the treatment of #peanutallergy.

[Georgia Life Sciences @Georgia_Bio]

Our Innovation Stage, sponsored by @atdc and Biolocity, will showcase entrepreneurs and innovative scientists who want to share their new inventions with leaders attending the #GaBioSummit. Be sure to check out who will take the stage this year: https://t.co/4GglRPlmfc